---
title: DDW track at SLAS2026
description: DDW track at SLAS2026
---

[![DDW-Logo](https://info.edifydigitalmedia.com/hs-fs/hubfs/DDW-Logo.png?width=239&height=121&name=DDW-Logo.png "DDW-Logo")](https://www.edifydigitalmedia.com/)

![Ignite Theat event landing page banner 1425px](https://info.edifydigitalmedia.com/hs-fs/hubfs/Ignite%20Theat%20event%20landing%20page%20banner%201425px.jpg?width=1425&height=400&name=Ignite%20Theat%20event%20landing%20page%20banner%201425px.jpg "Ignite Theat event landing page banner 1425px")

Register your interest now for DDW track at SLAS2026

 

 

 

![In partership with SLAS logo\_200px-1](https://info.edifydigitalmedia.com/hs-fs/hubfs/In%20partership%20with%20SLAS%20logo_200px-1.jpg?width=236&height=118&name=In%20partership%20with%20SLAS%20logo_200px-1.jpg)

---

 

For the third year running DDW is organising a series of seminars at SLAS International Conference and Exhibition. Based on the SLAS2026 theme of Catalyze Discovery, these will be available to visitors of SLAS2026 (7-11 February 2026, Boston, USA).

This programme, *Creating Cures: The role of lab automation in successful drug discovery at SLAS2026* - will highlight innovative research using technology in drug development and will be held in the Ignite Theater on 9 and 10 February.

Speakers confirmed:

- Mel Leveridge, Vice President, Assays, Profiling & Cell Sciences, Astra Zeneca: *The Role of Automation in Discovery at AstraZeneca*
- Mike Ouren, Director of Business Development, Brooks Automation: *Top 5 Challenges to Consider When Automating Drug Discovery Lab Workflows*
- Kelly Bachovchin PhD, Customer Engagement Scientist, Collaborative Drug Discovery:*Interoperable Automation: Real-Time Dataflows to Close DMTA Cycles*
- James Pena, Director, Product Management - Digital Science & Automation Solutions, Thermo Fisher Scientific: *From Data to Decisions: Digital-Ready Laboratories Powered by Automation*
- *Dr. Gabe Musso, Chief Scientific Officer, Lunai BioworksDe-Risking the Translation Gap: Coupling AI with High-Throughput In Vivo Models*
- Dr. Preeti Ashok, Head of Cell Biology (Novoheart), Medera: *From Animal Models to Human Mini-Hearts: How Automated Human-Based Testing is Revolutionizing Drug Discovery.*

![](https://info.edifydigitalmedia.com/hs-fs/hubfs/SLAS-Sponsor-logos-image_500px-jpg.jpeg?width=434&height=78&name=SLAS-Sponsor-logos-image_500px-jpg.jpeg)

 

 

 

### There are limited free places available so register your interest here.

## Copyright 2022 Drug Discovery World. All Rights Reserved Privacy Policy & Cookies | Contact | Terms & Conditions